Skip to main content

Table 1 Demographic and medical characteristics of the sample

From: Stigmas, symptom severity and perceived social support predict quality of life for PLHIV in urban Indian context

 

Mean

SD

Range

Age (years)

33.12

7.16

18–68

Household monthly income (Rupees)*

4548.18

6674.39

0–150,000

 

N

%

HRQoL M (SD)

Gender

 Male

396

41.2

84.82 (17.29)

 Female

534

55.6

82.94 (17.01)

 Hijra

31

3.2

84.50 (20.39)

Female

 Sex worker

208

39.0

82.55 (16.27)

 Not sex worker

326

61.0

83.20 (17.49)

Male/Hijra

 Have sex with men

68

15.9

83.71 (16.92)

 Not have sex with men

359

84.1

86.24 (15.03)

Site*

 Bangalore

511

53.2

87.06 (15.29)

 Mumbai

450

46.8

79.29 (18.73)

Religion

 Hindu

777

80.9

84.46 (16.83)

 Muslim

98

10.2

79.10 (19.07)

 Christian

51

5.3

83.61 (18.53)

 Buddhist

30

3.1

78.49 (17.27)

 Other

5

.5

96.70 (16.94)

Marital status*

 Never married/singlea

154

16.0

88.28 (17.45)

 Currently marriedb

430

44.7

83.27 (17.67)

 Divorced/separateda,b

57

5.9

84.36 (16.60)

 Widow/widowerb

255

26.5

82.80 (16.32)

 Desertedb

64

6.7

80.52 (16.92)

Children*

 No

256

26.6

87.03 (16.69)

 Yes

705

73.4

82.62 (17.31)

Educational level*

 Nonea

245

25.5

79.57 (16.80)

 7 years or lessa,b

249

25.9

82.22 (17.93)

 8–10 yearsb,c

331

34.4

86.35 (16.82)

 More than 10 yearsc

134

13.9

87.74 (16.00)

Currently employed*

 Yes

743

77.3

85.05 (16.82)

 No

218

22.7

79.35 (18.02)

Taking ART

 Yes

528

54.9

83.12 (17.49)

 No

433

45.1

84.59 (16.94)

  1. The sample (N = 961) was collected in Bangalore and Mumbai, India, between 2007 and 2009. The asterisk (*) indicates variables with a significant correlation with HRQoL or with significant HRQoL mean differences among categories. For variables with more than two categories, those with a different superscript letter show a significant difference in HRQoL mean
  2. HRQoL health-related quality of life, M mean, SD standard deviation, N number of participants, % percentage of participants, ART antiretroviral treatment